|
| |
| | | | 1 | | | DO1.PCCNTR.1255160 ContractData Container |
| | | 1.1 | | | | | | | | | | 484,649,100.00 | 0.00 | 0.00 | 0.00 | 483,326,100.00 | 484,649,100.00 |
|
| | | | | | | 17 | | 2.3.4.1.01 | Daratumumab 400 mg/ 20 ml vial | 2,000 | UD | 100,872 | 100,872 | 201,744,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 201,744,000.00 | 201,744,000.00 | |
|
| | | | | | | 18 | | 2.3.4.1.01 | Golimumab 50 mg / 1 ml jeringa precargada | 1,500 | UD | 35,096 | 35,096 | 52,644,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 52,644,000.00 | 52,644,000.00 | |
|
| | | | | | | 19 | | 2.3.4.1.01 | Guselkumab 100 mg / 1 ml jeringa precargada | 100 | UD | 96,152 | 96,152 | 9,615,200.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 9,615,200.00 | 9,615,200.00 | |
|
| | | | | | | 20 | | 2.3.4.1.01 | Ibrutinib 140 mg tab. | 29,610 | UD | 4,300 | 4,300 | 127,323,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 127,323,000.00 | 127,323,000.00 | |
|
| | | | | | | 21 | | 2.3.4.1.01 | Infliximab 100 mg / 10 ml vial (Innovador) | 1,500 | UD | 19,640 | 20,522 | 30,783,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 29,460,000.00 | 30,783,000.00 | |
|
| | | | | | | 25 | | 51201901 - Acetato de gla(...)51201901 - Acetato de glatiramer |
| 2.3.4.1.01 | Ustekinumab 45 mg / 0.5 ml jeringa precargada | 200 | UD | 154,899 | 154,899 | 30,979,800.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 30,979,800.00 | 30,979,800.00 | |
|
| | | | | | | 26 | | 51201901 - Acetato de gla(...)51201901 - Acetato de glatiramer |
| 2.3.4.1.01 | Ustekinumab 90 mg / 1 ml jeringa precargada | 110 | UD | 286,910 | 286,910 | 31,560,100.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 31,560,100.00 | 31,560,100.00 | |
|
|
| | | |
| | | |
|